Sandro L. Jube, Ph.D.
Affiliations: | 2009 | University of Hawai'i at Manoa, Honolulu, HI |
Area:
Molecular Biology, Plant Culture AgricultureGoogle:
"Sandro Jube"Parents
Sign in to add mentorDulal Borthakur | grad student | 2009 | University of Hawai'i at Manoa | |
(Genetic transformation of Leucaena leucocephala for reduction of mimosine content.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Pellegrini L, Xue J, Larson D, et al. (2017) HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma. Oncotarget |
Yang H, Pellegrini L, Napolitano A, et al. (2015) Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death & Disease. 6: e1786 |
Yang H, Jube S, Carbone M. (2015) Abstract A36: Novel therapeutic approaches for human malignant mesothelioma Cancer Immunology Research. 3 |
Qi F, Okimoto G, Jube S, et al. (2013) Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling. The American Journal of Pathology. 183: 1654-66 |
Jube SL, Rivera Z, Casalgrandi M, et al. (2013) Abstract 5557: BoxA and ethyl pyruvate offer novel therapeutic approaches for human malignant mesothelioma. Cancer Research. 73: 5557-5557 |
Qi F, Okimoto G, Jube S, et al. (2013) Abstract 3588: Common and different effects induced in primary human mesothelial cells and mice exposed to chrysotile or crocidolite asbestos. Cancer Research. 73: 3588-3588 |
Napolitano A, Pellegrini L, Jube S, et al. (2013) Abstract C187: Salicylates suppress tumor growth via inhibition of HMGB1. Molecular Cancer Therapeutics. 12 |
Rivera Z, Ferrone S, Wang X, et al. (2012) CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5352-63 |
Jube S, Rivera ZS, Bianchi ME, et al. (2012) Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Research. 72: 3290-301 |
Jube S, Rivera Z, Bianchi M, et al. (2012) Abstract 1557: High mobility group box 1 secretion supports tumor progression of human malignant mesothelioma Cancer Research. 72: 1557-1557 |